• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy for metastatic renal cell carcinoma.

作者信息

McDermott David F, Rini Brian I

机构信息

DF/HCC Renal Cancer Program, Beth Israel Deaconess Medical Center, Boston, MA, USA.

出版信息

BJU Int. 2007 May;99(5 Pt B):1282-8. doi: 10.1111/j.1464-410X.2007.06818.x.

DOI:10.1111/j.1464-410X.2007.06818.x
PMID:17441925
Abstract
摘要

相似文献

1
Immunotherapy for metastatic renal cell carcinoma.转移性肾细胞癌的免疫疗法。
BJU Int. 2007 May;99(5 Pt B):1282-8. doi: 10.1111/j.1464-410X.2007.06818.x.
2
Immunotherapy for renal cell carcinoma.肾细胞癌的免疫治疗。
Hematol Oncol Clin North Am. 2011 Aug;25(4):793-812. doi: 10.1016/j.hoc.2011.04.010.
3
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.2006年及以后细胞因子疗法在转移性肾细胞癌治疗中的作用
J Clin Oncol. 2006 Dec 10;24(35):5584-92. doi: 10.1200/JCO.2006.08.1638.
4
[Preliminary findings on clinical and immunological effects of subcutaneously administered interleukin-2 + alpha-interferon combination in the treatment of advanced renal carcinoma].[皮下注射白细胞介素-2与α-干扰素联合治疗晚期肾癌的临床及免疫学效果初步研究]
Recenti Prog Med. 1995 Jul-Aug;86(7-8):304-5.
5
Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, alpha-interferon (leucocyte) and tamoxifen.肾细胞癌的生存率：他莫昔芬与白细胞介素-2、α干扰素（白细胞）及他莫昔芬的随机对照评估
Br J Cancer. 2000 Jan;82(1):246-7. doi: 10.1054/bjoc.1999.0952.
6
Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.α干扰素与低剂量白细胞介素-2联合免疫疗法治疗日本转移性肾细胞癌患者的临床疗效
Urol Oncol. 2009 Nov-Dec;27(6):598-603. doi: 10.1016/j.urolonc.2008.07.023. Epub 2008 Sep 25.
7
[Treatment of renal cell carcinoma with interferons].[干扰素治疗肾细胞癌]
Nihon Rinsho. 2006 Jul;64(7):1281-5.
8
Current clinical practice of induction and maintenance immunotherapy for metastatic renal cell carcinoma.转移性肾细胞癌诱导和维持免疫治疗的当前临床实践。
Int J Clin Pract. 2002 Jan-Feb;56(1):36-9.
9
Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.白细胞介素-2与α干扰素联合生物疗法用于转移性肾细胞癌的门诊治疗
Semin Oncol. 1993 Dec;20(6 Suppl 9):11-5.
10
[Immunotherapeutic treatment for metastatic renal carcinoma].
Actas Urol Esp. 1998 Jan;22(1):29-33.

引用本文的文献

1
The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features.透明细胞肾细胞癌中血管生成拟态的分类揭示了其与临床及免疫特征的内在联系。
Front Pharmacol. 2023 Dec 20;14:1333507. doi: 10.3389/fphar.2023.1333507. eCollection 2023.
2
Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer.转移性透明细胞肾细胞癌抗血管生成治疗的预后及疗效生物标志物
Front Oncol. 2019 Dec 11;9:1400. doi: 10.3389/fonc.2019.01400. eCollection 2019.
3
Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma.
Mol Biol Rep. 2014 Jun;41(6):3651-7. doi: 10.1007/s11033-014-3229-z. Epub 2014 Feb 16.
4
State of the science: an update on renal cell carcinoma.科学现状：肾细胞癌的最新进展。
Mol Cancer Res. 2012 Jul;10(7):859-80. doi: 10.1158/1541-7786.MCR-12-0117. Epub 2012 May 25.
5
Treatment selection in metastatic renal cell carcinoma: expert consensus.转移性肾细胞癌的治疗选择：专家共识。
Nat Rev Clin Oncol. 2012 Apr 10;9(6):327-37. doi: 10.1038/nrclinonc.2012.59.
6
Circulating biomarkers in advanced renal cell carcinoma: clinical applications.晚期肾细胞癌的循环生物标志物：临床应用。
Curr Oncol Rep. 2012 Jun;14(3):221-9. doi: 10.1007/s11912-012-0231-2.
7
Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients.RCC 的原位异种移植保留了患者肿瘤的组织学、免疫表型和遗传特征。
J Pathol. 2011 Oct;225(2):212-21. doi: 10.1002/path.2929. Epub 2011 Jun 27.
8
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab.肾细胞癌治疗中的靶向疗法：贝伐单抗的作用
Biologics. 2008 Sep;2(3):517-30. doi: 10.2147/btt.s3509.
9
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.冯·希佩尔-林道病相关及散发性肾透明细胞癌中的基因表达模式和拷贝数改变
Cancer Res. 2009 Jun 1;69(11):4674-81. doi: 10.1158/0008-5472.CAN-09-0146.